We are live on ! Find out more
DA

Duality Advisers Portfolio holdings

AUM $1.01B
1-Year Est. Return 14.52%
This Fund
S&P 500
This Quarter Est. Return
-7.72%
1 Year Est. Return
+14.52%
3 Year Est. Return
-18.25%
5 Year Est. Return
10 Year Est. Return
AUM
$932M
AUM Growth
+$8.16M
Cap. Flow
+$71.3M
Cap. Flow %
7.66%
Top 10 Hldgs %
6.08%
Holding
879
New
413
Increased
82
Reduced
112
Closed
272

Top Buys

Rank Stock Value
1
KOD icon
Kodiak Sciences
KOD
+$6.46M
2
ABT icon
Abbott
ABT
+$6M
3
CL icon
Colgate-Palmolive
CL
+$5.99M
4
PM icon
Philip Morris
PM
+$5.97M
5
VZ icon
Verizon
VZ
+$5.95M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$6.7M
2
K
Kellanova
K
+$6.65M
3
TXN icon
Texas Instruments
TXN
+$6.64M
4
ORCL icon
Oracle
ORCL
+$6.62M
5
LHX icon
L3Harris
LHX
+$6.61M

Sector Composition

Rank Sector Weight
1 Industrials 16.44%
2 Technology 15.1%
3 Financials 13.87%
4 Healthcare 12.33%
5 Consumer Discretionary 12.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
1
Abbott
ABT
$183B
$5.73M 0.62%
+48,411
New +$6M
CL icon
2
Colgate-Palmolive
CL
$74.2B
$5.73M 0.62%
+75,569
New +$5.99M
AIZ icon
3
Assurant
AIZ
$13.8B
$5.72M 0.61%
31,482
+131
+0.4% +$21.5K
VZ icon
4
Verizon
VZ
$198B
$5.72M 0.61%
+112,315
New +$5.95M
CVS icon
5
CVS Health
CVS
$136B
$5.71M 0.61%
+56,436
New +$5.93M
UGI icon
6
UGI
UGI
$8.02B
$5.69M 0.61%
157,091
+130,133
+483% +$5.21M
SPGI icon
7
S&P Global
SPGI
$130B
$5.64M 0.61%
13,761
+9,028
+191% +$3.68M
PM icon
8
Philip Morris
PM
$306B
$5.61M 0.6%
+59,677
New +$5.97M
HWM icon
9
Howmet Aerospace
HWM
$114B
$5.56M 0.6%
+154,700
New +$5.28M
SPG icon
10
Simon Property Group
SPG
$74.9B
$5.55M 0.6%
42,196
+35,861
+566% +$5.11M
TGT icon
11
Target
TGT
$63.9B
$5.48M 0.59%
25,826
-2,775
-10% -$600K
WCN
12
Waste Connections
WCN
$43.1B
$5.47M 0.59%
+39,193
New +$5.02M
BAX icon
13
Baxter International
BAX
$12B
$5.43M 0.58%
+70,055
New +$5.87M
HD icon
14
Home Depot
HD
$339B
$5.42M 0.58%
18,110
+13,050
+258% +$4.53M
HR
15
DELISTED
Healthcare Realty Trust Incorporated
HR
$5.36M 0.58%
195,078
+122,100
+167% +$3.6M
CBRE icon
16
CBRE Group
CBRE
$42.1B
$5.31M 0.57%
+58,046
New +$5.66M
BIO icon
17
Bio-Rad Laboratories Class A
BIO
$8.53B
$5.27M 0.57%
+9,349
New +$5.64M
CSCO icon
18
Cisco
CSCO
$445B
$5.2M 0.56%
+93,272
New +$5.28M
DD icon
19
DuPont de Nemours
DD
$18.7B
$5.09M 0.55%
55,129
+32,410
+143% +$3.16M
PXD
20
DELISTED
Pioneer Natural Resource Co.
PXD
$5.02M 0.54%
20,062
+14,269
+246% +$3.23M
EG icon
21
Everest Group
EG
$15.4B
$5M 0.54%
+16,600
New +$4.77M
MCO icon
22
Moody's
MCO
$84.8B
$4.89M 0.52%
14,497
+2,458
+20% +$827K
QCOM icon
23
Qualcomm
QCOM
$175B
$4.86M 0.52%
31,775
+28,939
+1,020% +$4.85M
XEL icon
24
Xcel Energy
XEL
$51.2B
$4.85M 0.52%
67,233
+28,503
+74% +$1.96M
PNR icon
25
Pentair
PNR
$10.4B
$4.85M 0.52%
89,398
-1,144
-1% -$69.2K

Similar funds

Duality Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, Duality Advisers held 879 positions worth $932M, up 0.88% from $924M the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Duality Advisers deployed $71.3M of net new capital in Q1 2022, opening 413 new positions and adding to 82 existing holdings. Its largest new stake was Kodiak Sciences: 165,627 shares worth $1.28M.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was ExxonMobil, an estimated $5.97M trimmed.

  • Duality Advisers's largest Q1 2022 buy was Kodiak Sciences: 165,627 shares worth $1.28M.
  • Duality Advisers added most to UGI in Q1 2022, an estimated $5.21M increase.
  • Duality Advisers's biggest Q1 2022 reduction was ExxonMobil, cutting an estimated $5.97M.
  • Duality Advisers fully exited PepsiCo in Q1 2022, selling an estimated $6.7M.
  • Duality Advisers's ten largest holdings make up 6.1% of its $932M portfolio in Q1 2022.
  • Duality Advisers opened 413 new positions and closed 272 in Q1 2022.
  • Duality Advisers's portfolio value rose 0.88% quarter-over-quarter to $932M.

Based on Duality Advisers's 13F filing for Q1 2022, filed 9 May 2022.